Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US

Eligibility Criteria

• * a. Adults aged above 18 years old who have at least one indication for TE examination determined by the physicians;
• * b. Patients who have test results for platelet count, ALT, AST, globulin, HBA1c, and total bilirubin (TBIL) levels within 60 days;
• * c. Patients who are willing to participate in the clinical study and can sign ICF.
• * a. Excessive drinking history within 90 days: For women-140 grams of alcohol per week or more; For men-210 grams of alcohol per week or more;
• * b. Patients with alanine aminotransferase (ALT) or aspartate aminotransferase AST \>100 U/ml (or 2.5 × upper limit of normal (ULN) and/or total bilirubin (TBIL) \> 1.8 mg/d (or \>1.5 × ULN =1.2 mg/d);
• * c. Patients with a history or current evidence of decompensated liver cirrhosis;
• * d. Patients with various space-occupying tumors and cysts in the right liver;
• * e. Patients with other serious systemically diseases or a history of malignant tumors;
• * f. Patients with ascites;
• * g. Patients with a non-healing wound on the right upper abdomen at this moment;
• * h. Patients with intracavitary implantation of instruments;
• * i. Pregnant women (urine pregnancy test should be performed for all women with child-bearing potential during screening);
• * j. Any history of organ transplantation and existing functional grafts (except corneal or hair transplantation);
• * k. Lack of or limited legal capacity.